本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

89Bio, Inc.

9.95
-0.2700-2.64%
盘后9.950.00000.00%16:20 EDT
成交量:114.42万
成交额:1,150.42万
市值:14.53亿
市盈率:-3.02
高:10.38
开:10.23
低:9.92
收:10.22
数据加载中...
2023/06/09

重要事件披露

Form 8-K - Current report
2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/09

关联方拟减持公告

144 - Report of proposed sale of securities
2023/05/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/04

重要事件披露

8-K - Current report
2023/03/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/28

重要事件披露

8-K - Current report
2023/03/24

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/03/22

重要事件披露

8-K - Current report
2023/03/15

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/10

重要事件披露

8-K - Current report
2023/02/16

重要事件披露

8-K - Current report
2023/02/15

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals